IgG antibodies binding to the variable regions 1–2 (V1V2) of the HIV-1 Envelope (Env) have been shown to correlate with decreased risk of infection, while IgA binding to Env associated with increased risk of infection (Haynes et al., 2012). The gene discussed is CD79A; the disease is infection.